| 前收市價 | 1.6000 |
| 開市 | 1.6000 |
| 買盤 | 0.5000 |
| 賣出價 | 1.1000 |
| 拍板 | 65.00 |
| 到期日 | 2024-05-17 |
| 今日波幅 | 1.6000 - 1.6000 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 21 |
ZacksFDA Delays Decision on Ascendis' (ASND) Hormone Therapy Filing
Per the FDA, the data submitted by Ascendis (ASND) for its hormone replacement therapy constitutes a major amendment to its previously-submitted data. A final decision is expected by Aug 14.
- Zacks
Allogene (ALLO) Q1 Earnings in Line With Estimates, Sales Lag
Allogene (ALLO) reports drab first-quarter 2024 results. The company secures the development and marketing rights to its CD19 oncology program in Europe.
ZacksNovo Nordisk (NVO) Up 3% as Haemophilia Drug Meets Study Goals
Novo Nordisk's (NVO) shares rise 3.1% as the company meets co-primary endpoints in a late-stage study evaluating its investigational candidate, Mim8, for the treatment of haemophilia A.
